Concepts (288)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spectroscopy, Near-Infrared | 9 | 2018 | 741 | 1.910 |
Why?
|
Cerebrovascular Circulation | 12 | 2021 | 2733 | 1.820 |
Why?
|
Brain Mapping | 25 | 2022 | 6569 | 1.460 |
Why?
|
Magnetic Resonance Imaging | 51 | 2022 | 36286 | 1.440 |
Why?
|
Brain | 41 | 2022 | 26951 | 1.300 |
Why?
|
Oxygen | 19 | 2022 | 4193 | 0.740 |
Why?
|
Artifacts | 7 | 2022 | 1898 | 0.670 |
Why?
|
Nicotine | 3 | 2021 | 677 | 0.650 |
Why?
|
Heart Rate | 6 | 2022 | 4180 | 0.620 |
Why?
|
Tobacco Use Disorder | 8 | 2019 | 700 | 0.620 |
Why?
|
Blood Flow Velocity | 3 | 2021 | 1377 | 0.560 |
Why?
|
Magnetic Resonance Spectroscopy | 16 | 2007 | 3765 | 0.530 |
Why?
|
Cues | 8 | 2020 | 867 | 0.490 |
Why?
|
Image Processing, Computer-Assisted | 11 | 2022 | 8950 | 0.460 |
Why?
|
Hypercapnia | 1 | 2015 | 261 | 0.460 |
Why?
|
Image Interpretation, Computer-Assisted | 6 | 2018 | 3340 | 0.460 |
Why?
|
Smoking | 9 | 2013 | 9073 | 0.430 |
Why?
|
Image Enhancement | 4 | 2019 | 2881 | 0.420 |
Why?
|
Gyrus Cinguli | 7 | 2018 | 1114 | 0.380 |
Why?
|
Echo-Planar Imaging | 3 | 2013 | 657 | 0.370 |
Why?
|
Aspartic Acid | 4 | 2004 | 576 | 0.370 |
Why?
|
Smoking Cessation | 4 | 2021 | 2064 | 0.340 |
Why?
|
Cerebral Cortex | 6 | 2019 | 5761 | 0.330 |
Why?
|
Rest | 2 | 2013 | 914 | 0.320 |
Why?
|
Cerebrovascular Disorders | 1 | 2015 | 1501 | 0.310 |
Why?
|
gamma-Aminobutyric Acid | 6 | 2018 | 1132 | 0.300 |
Why?
|
Behavior, Addictive | 1 | 2012 | 462 | 0.280 |
Why?
|
Hemodynamics | 4 | 2022 | 4173 | 0.280 |
Why?
|
Nerve Net | 5 | 2019 | 2261 | 0.260 |
Why?
|
Oxygen Consumption | 1 | 2012 | 1843 | 0.250 |
Why?
|
Temporal Lobe | 3 | 2015 | 1688 | 0.240 |
Why?
|
Creatine | 3 | 2018 | 426 | 0.230 |
Why?
|
Adult | 49 | 2021 | 220007 | 0.230 |
Why?
|
Marijuana Smoking | 1 | 2007 | 257 | 0.220 |
Why?
|
Signal Processing, Computer-Assisted | 4 | 2018 | 1489 | 0.220 |
Why?
|
Occipital Lobe | 3 | 2015 | 373 | 0.210 |
Why?
|
Thiadiazoles | 1 | 2002 | 64 | 0.190 |
Why?
|
Muscarinic Agonists | 1 | 2002 | 91 | 0.190 |
Why?
|
Choline | 5 | 2004 | 513 | 0.190 |
Why?
|
Sea Lions | 1 | 2021 | 7 | 0.190 |
Why?
|
Depression, Postpartum | 2 | 2018 | 345 | 0.190 |
Why?
|
Protons | 3 | 2007 | 1114 | 0.190 |
Why?
|
Oxyhemoglobins | 3 | 2018 | 212 | 0.170 |
Why?
|
Prefrontal Cortex | 4 | 2014 | 2212 | 0.170 |
Why?
|
Male | 50 | 2021 | 359718 | 0.170 |
Why?
|
Glutamine | 2 | 2007 | 576 | 0.170 |
Why?
|
Humans | 71 | 2022 | 760613 | 0.170 |
Why?
|
Female | 51 | 2021 | 391246 | 0.160 |
Why?
|
Regression Analysis | 6 | 2021 | 6359 | 0.160 |
Why?
|
Oximetry | 2 | 2013 | 461 | 0.160 |
Why?
|
Photic Stimulation | 8 | 2015 | 1967 | 0.160 |
Why?
|
Superior Sagittal Sinus | 1 | 2018 | 15 | 0.150 |
Why?
|
Moyamoya Disease | 2 | 2019 | 255 | 0.150 |
Why?
|
Visual Cortex | 3 | 2009 | 1089 | 0.150 |
Why?
|
Psychotropic Drugs | 2 | 2007 | 883 | 0.140 |
Why?
|
Biological Clocks | 2 | 2018 | 316 | 0.140 |
Why?
|
Pregnanolone | 2 | 2018 | 67 | 0.140 |
Why?
|
Jugular Veins | 1 | 2018 | 211 | 0.140 |
Why?
|
Cerebral Arterial Diseases | 1 | 2017 | 82 | 0.140 |
Why?
|
Young Adult | 15 | 2019 | 58748 | 0.130 |
Why?
|
Toes | 2 | 2018 | 209 | 0.130 |
Why?
|
N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2006 | 64 | 0.130 |
Why?
|
Alzheimer Disease | 3 | 2004 | 8561 | 0.130 |
Why?
|
Constriction, Pathologic | 2 | 2017 | 1098 | 0.130 |
Why?
|
Hemoglobins | 2 | 2011 | 1521 | 0.120 |
Why?
|
Fructose | 1 | 2006 | 287 | 0.120 |
Why?
|
Parietal Lobe | 2 | 2012 | 850 | 0.120 |
Why?
|
Cerebral Arteries | 1 | 2017 | 493 | 0.120 |
Why?
|
Caffeine | 1 | 2018 | 702 | 0.110 |
Why?
|
Fingers | 2 | 2018 | 506 | 0.110 |
Why?
|
Algorithms | 5 | 2019 | 13982 | 0.110 |
Why?
|
Respiration | 1 | 2020 | 1654 | 0.110 |
Why?
|
Reproducibility of Results | 4 | 2022 | 20080 | 0.110 |
Why?
|
Pregnenolone | 1 | 2013 | 27 | 0.110 |
Why?
|
Cardiovascular System | 1 | 2021 | 850 | 0.110 |
Why?
|
Carotid Arteries | 1 | 2018 | 951 | 0.110 |
Why?
|
Caudate Nucleus | 2 | 2013 | 389 | 0.110 |
Why?
|
Inositol | 2 | 2004 | 215 | 0.100 |
Why?
|
Nonlinear Dynamics | 1 | 2014 | 494 | 0.100 |
Why?
|
Perfusion | 1 | 2016 | 1376 | 0.100 |
Why?
|
Carbon Dioxide | 1 | 2015 | 1146 | 0.090 |
Why?
|
Macaca fascicularis | 1 | 2013 | 900 | 0.090 |
Why?
|
Attention | 2 | 2013 | 2387 | 0.090 |
Why?
|
Optical Phenomena | 1 | 2011 | 105 | 0.090 |
Why?
|
Mental Status Schedule | 2 | 2004 | 314 | 0.090 |
Why?
|
Nucleus Accumbens | 1 | 2013 | 365 | 0.090 |
Why?
|
Sex Characteristics | 1 | 2021 | 2629 | 0.090 |
Why?
|
Magnetic Resonance Angiography | 1 | 2017 | 1431 | 0.090 |
Why?
|
Pyridines | 1 | 2002 | 2879 | 0.090 |
Why?
|
Limbic System | 1 | 2012 | 419 | 0.080 |
Why?
|
Suprachiasmatic Nucleus | 1 | 2009 | 139 | 0.080 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2009 | 352 | 0.080 |
Why?
|
Receptors, Nicotinic | 1 | 2011 | 494 | 0.080 |
Why?
|
Self Administration | 1 | 2009 | 390 | 0.070 |
Why?
|
Task Performance and Analysis | 1 | 2011 | 759 | 0.070 |
Why?
|
Visual Perception | 1 | 2015 | 1374 | 0.070 |
Why?
|
Glutamic Acid | 2 | 2007 | 1167 | 0.070 |
Why?
|
Memory, Short-Term | 1 | 2013 | 978 | 0.070 |
Why?
|
Fluorine Compounds | 1 | 2006 | 6 | 0.070 |
Why?
|
Hypocapnia | 1 | 2006 | 38 | 0.070 |
Why?
|
Emotions | 4 | 2015 | 2734 | 0.070 |
Why?
|
Spectrophotometry, Infrared | 1 | 2006 | 116 | 0.070 |
Why?
|
Anticonvulsants | 1 | 2006 | 1879 | 0.070 |
Why?
|
Brain Ischemia | 1 | 2020 | 3127 | 0.070 |
Why?
|
Phantoms, Imaging | 5 | 2009 | 2512 | 0.070 |
Why?
|
Cognition | 2 | 2015 | 6964 | 0.070 |
Why?
|
Affect | 2 | 2007 | 1480 | 0.070 |
Why?
|
Middle Aged | 21 | 2020 | 220359 | 0.060 |
Why?
|
Administration, Inhalation | 1 | 2009 | 1156 | 0.060 |
Why?
|
Stress Disorders, Post-Traumatic | 3 | 2009 | 4555 | 0.060 |
Why?
|
Amygdala | 2 | 2013 | 1351 | 0.060 |
Why?
|
Time Factors | 4 | 2015 | 40139 | 0.060 |
Why?
|
Smoke | 1 | 2007 | 236 | 0.060 |
Why?
|
Plaque, Atherosclerotic | 1 | 2017 | 1518 | 0.060 |
Why?
|
Noise | 1 | 2007 | 280 | 0.060 |
Why?
|
Anti-Allergic Agents | 1 | 2006 | 149 | 0.060 |
Why?
|
Visual Pathways | 1 | 2009 | 534 | 0.060 |
Why?
|
Cerebrospinal Fluid | 1 | 2007 | 544 | 0.060 |
Why?
|
Combat Disorders | 1 | 2006 | 301 | 0.060 |
Why?
|
Hippocampus | 3 | 2021 | 3738 | 0.060 |
Why?
|
Models, Neurological | 1 | 2011 | 1758 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2015 | 22052 | 0.050 |
Why?
|
Analysis of Variance | 3 | 2009 | 6238 | 0.050 |
Why?
|
Skull | 1 | 2007 | 815 | 0.050 |
Why?
|
Cocaine-Related Disorders | 1 | 2006 | 460 | 0.050 |
Why?
|
Photons | 1 | 2006 | 581 | 0.050 |
Why?
|
Reward | 1 | 2009 | 963 | 0.050 |
Why?
|
Adolescent | 9 | 2022 | 87809 | 0.050 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2017 | 3701 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 2 | 2013 | 4046 | 0.050 |
Why?
|
Nerve Tissue Proteins | 2 | 2013 | 4408 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2696 | 0.050 |
Why?
|
Hemodilution | 1 | 2001 | 120 | 0.050 |
Why?
|
Basal Ganglia | 2 | 2001 | 552 | 0.050 |
Why?
|
Hand | 1 | 2006 | 903 | 0.050 |
Why?
|
Benzimidazoles | 1 | 2006 | 858 | 0.050 |
Why?
|
Phosphocreatine | 4 | 2006 | 261 | 0.050 |
Why?
|
Atherosclerosis | 1 | 2017 | 3518 | 0.050 |
Why?
|
Equipment Design | 1 | 2009 | 3520 | 0.050 |
Why?
|
Hematocrit | 1 | 2001 | 629 | 0.040 |
Why?
|
Cocaine | 2 | 2006 | 961 | 0.040 |
Why?
|
Color Perception | 1 | 2000 | 212 | 0.040 |
Why?
|
Functional Laterality | 1 | 2006 | 2253 | 0.040 |
Why?
|
Adenosine Triphosphate | 2 | 2006 | 1993 | 0.040 |
Why?
|
Substance-Related Disorders | 1 | 2006 | 4371 | 0.040 |
Why?
|
Administration, Cutaneous | 1 | 2002 | 713 | 0.040 |
Why?
|
Water-Electrolyte Balance | 1 | 2000 | 325 | 0.040 |
Why?
|
Cerebellum | 1 | 2006 | 1495 | 0.040 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2003 | 622 | 0.040 |
Why?
|
Aged, 80 and over | 5 | 2020 | 58980 | 0.040 |
Why?
|
Neurons | 2 | 2018 | 9424 | 0.040 |
Why?
|
Ear Auricle | 1 | 2018 | 31 | 0.040 |
Why?
|
Purines | 1 | 2001 | 605 | 0.040 |
Why?
|
Depressive Disorder, Major | 4 | 2006 | 4744 | 0.040 |
Why?
|
Stress, Psychological | 2 | 2013 | 4446 | 0.040 |
Why?
|
Principal Component Analysis | 2 | 2012 | 939 | 0.040 |
Why?
|
Retina | 1 | 2009 | 2635 | 0.040 |
Why?
|
Stroke | 1 | 2020 | 9952 | 0.040 |
Why?
|
Piperidines | 1 | 2006 | 1650 | 0.040 |
Why?
|
Myocardium | 2 | 2006 | 4700 | 0.040 |
Why?
|
Angiography, Digital Subtraction | 1 | 2019 | 334 | 0.040 |
Why?
|
Memory Disorders | 1 | 2004 | 1197 | 0.040 |
Why?
|
Respiratory Mechanics | 1 | 2011 | 699 | 0.040 |
Why?
|
Memory | 3 | 2013 | 2179 | 0.040 |
Why?
|
Gulf War | 2 | 2007 | 33 | 0.040 |
Why?
|
Circadian Rhythm | 1 | 2009 | 2570 | 0.040 |
Why?
|
Analgesics, Opioid | 1 | 2013 | 3763 | 0.040 |
Why?
|
Brain Chemistry | 2 | 1999 | 959 | 0.030 |
Why?
|
Bipolar Disorder | 2 | 2007 | 5078 | 0.030 |
Why?
|
Vietnam Conflict | 2 | 2007 | 100 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14661 | 0.030 |
Why?
|
Cerebral Revascularization | 1 | 2019 | 249 | 0.030 |
Why?
|
Vasoconstriction | 1 | 2018 | 593 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2022 | 830 | 0.030 |
Why?
|
Models, Statistical | 1 | 2010 | 5075 | 0.030 |
Why?
|
Feces | 1 | 2022 | 1455 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2021 | 2061 | 0.030 |
Why?
|
Alcoholism | 1 | 2006 | 1961 | 0.030 |
Why?
|
Phosphates | 2 | 2006 | 772 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 4 | 2010 | 6015 | 0.030 |
Why?
|
Peripheral Vascular Diseases | 1 | 2018 | 515 | 0.030 |
Why?
|
Psychophysics | 1 | 2015 | 289 | 0.030 |
Why?
|
Neural Pathways | 2 | 2019 | 3040 | 0.030 |
Why?
|
Coffee | 1 | 2018 | 582 | 0.030 |
Why?
|
Aged | 8 | 2020 | 169143 | 0.030 |
Why?
|
Reference Values | 2 | 2001 | 4925 | 0.030 |
Why?
|
Sensory Thresholds | 2 | 2009 | 377 | 0.030 |
Why?
|
Benzeneacetamides | 1 | 2013 | 36 | 0.030 |
Why?
|
Leg | 1 | 2018 | 1091 | 0.030 |
Why?
|
Blood Pressure | 1 | 2009 | 8525 | 0.030 |
Why?
|
Blood Vessels | 1 | 2018 | 1112 | 0.030 |
Why?
|
Energy Metabolism | 2 | 2001 | 2869 | 0.030 |
Why?
|
Dementia | 2 | 2004 | 2650 | 0.030 |
Why?
|
Receptors, Opioid, mu | 1 | 2013 | 166 | 0.030 |
Why?
|
Receptors, Opioid, kappa | 1 | 2013 | 138 | 0.020 |
Why?
|
Veterans | 1 | 2006 | 2642 | 0.020 |
Why?
|
Tissue Distribution | 2 | 2006 | 2262 | 0.020 |
Why?
|
Restraint, Physical | 1 | 2013 | 186 | 0.020 |
Why?
|
Diphosphoglyceric Acids | 1 | 1991 | 31 | 0.020 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2013 | 618 | 0.020 |
Why?
|
Pyrrolidines | 1 | 2013 | 340 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2013 | 1385 | 0.020 |
Why?
|
Social Environment | 1 | 2015 | 1022 | 0.020 |
Why?
|
Stroop Test | 1 | 2010 | 71 | 0.020 |
Why?
|
Cognition Disorders | 1 | 2004 | 3976 | 0.020 |
Why?
|
Liver | 1 | 2006 | 7510 | 0.020 |
Why?
|
Fentanyl | 1 | 2013 | 434 | 0.020 |
Why?
|
Face | 1 | 2015 | 1017 | 0.020 |
Why?
|
Phosphorus | 2 | 2006 | 333 | 0.020 |
Why?
|
Internal-External Control | 1 | 2010 | 359 | 0.020 |
Why?
|
Fluoxetine | 2 | 2003 | 733 | 0.020 |
Why?
|
Rod Opsins | 1 | 2009 | 108 | 0.020 |
Why?
|
Heart | 1 | 2011 | 4393 | 0.020 |
Why?
|
Psychological Tests | 1 | 2009 | 639 | 0.020 |
Why?
|
Animals | 6 | 2022 | 167960 | 0.020 |
Why?
|
Hyperventilation | 1 | 2006 | 79 | 0.020 |
Why?
|
Postmortem Changes | 1 | 2006 | 119 | 0.020 |
Why?
|
Reaction Time | 1 | 2013 | 2075 | 0.020 |
Why?
|
Wakefulness | 1 | 2013 | 1255 | 0.020 |
Why?
|
Self Report | 1 | 2017 | 3711 | 0.020 |
Why?
|
Postpartum Period | 1 | 2013 | 1168 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2006 | 2502 | 0.020 |
Why?
|
Electroencephalography | 1 | 2011 | 6189 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2013 | 1398 | 0.020 |
Why?
|
Wechsler Scales | 1 | 2006 | 257 | 0.020 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2006 | 303 | 0.020 |
Why?
|
Vision, Ocular | 1 | 2009 | 454 | 0.020 |
Why?
|
Carbon Isotopes | 1 | 2006 | 459 | 0.020 |
Why?
|
Autoradiography | 1 | 2006 | 730 | 0.020 |
Why?
|
Lactic Acid | 2 | 2006 | 1134 | 0.020 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2012 | 1988 | 0.020 |
Why?
|
Hydrocortisone | 1 | 2013 | 1803 | 0.020 |
Why?
|
Half-Life | 1 | 2006 | 652 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2013 | 1878 | 0.010 |
Why?
|
Fluorine Radioisotopes | 1 | 2006 | 413 | 0.010 |
Why?
|
California | 1 | 2007 | 1416 | 0.010 |
Why?
|
Paroxetine | 1 | 2003 | 182 | 0.010 |
Why?
|
Retinal Ganglion Cells | 1 | 2009 | 805 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2006 | 1544 | 0.010 |
Why?
|
Thionucleotides | 1 | 2001 | 112 | 0.010 |
Why?
|
Neurotransmitter Agents | 1 | 2005 | 663 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2006 | 10826 | 0.010 |
Why?
|
Neuroglia | 1 | 2007 | 944 | 0.010 |
Why?
|
Dogs | 1 | 2006 | 3841 | 0.010 |
Why?
|
Atrophy | 1 | 2006 | 1626 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2010 | 64981 | 0.010 |
Why?
|
Alleles | 1 | 2011 | 6900 | 0.010 |
Why?
|
Lithium Carbonate | 1 | 2000 | 179 | 0.010 |
Why?
|
Aging | 1 | 1999 | 8652 | 0.010 |
Why?
|
Pilot Projects | 1 | 2013 | 8556 | 0.010 |
Why?
|
Putamen | 1 | 2000 | 291 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2006 | 1792 | 0.010 |
Why?
|
Dominance, Cerebral | 1 | 2000 | 622 | 0.010 |
Why?
|
Mental Disorders | 1 | 1999 | 6796 | 0.010 |
Why?
|
Valproic Acid | 1 | 2000 | 441 | 0.010 |
Why?
|
Body Water | 1 | 1999 | 341 | 0.010 |
Why?
|
Syndrome | 1 | 2003 | 3280 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2010 | 7022 | 0.010 |
Why?
|
Fourier Analysis | 1 | 1997 | 439 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2000 | 2235 | 0.010 |
Why?
|
Mice | 1 | 2022 | 81209 | 0.010 |
Why?
|
Massachusetts | 1 | 2007 | 8803 | 0.010 |
Why?
|
Estrogens | 1 | 2000 | 1520 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2022 | 80345 | 0.010 |
Why?
|
Dopamine | 1 | 2000 | 1595 | 0.010 |
Why?
|
Electroconvulsive Therapy | 1 | 1999 | 502 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 15790 | 0.010 |
Why?
|
2,3-Diphosphoglycerate | 1 | 1991 | 13 | 0.010 |
Why?
|
Comorbidity | 1 | 2006 | 10553 | 0.010 |
Why?
|
Glycerophosphates | 1 | 1991 | 47 | 0.010 |
Why?
|
Pregnancy | 1 | 2013 | 29746 | 0.010 |
Why?
|
Sodium Bicarbonate | 1 | 1991 | 62 | 0.010 |
Why?
|
Models, Structural | 1 | 1991 | 341 | 0.010 |
Why?
|
Deoxyglucose | 1 | 1991 | 333 | 0.010 |
Why?
|
Lactates | 1 | 1991 | 404 | 0.010 |
Why?
|
Bicarbonates | 1 | 1991 | 292 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2006 | 6465 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1991 | 2094 | 0.010 |
Why?
|
Age Factors | 1 | 2006 | 18413 | 0.010 |
Why?
|
Child | 2 | 2007 | 79799 | 0.010 |
Why?
|
Sex Factors | 1 | 2000 | 10546 | 0.000 |
Why?
|
Double-Blind Method | 1 | 2000 | 12427 | 0.000 |
Why?
|
Sodium | 1 | 1991 | 1594 | 0.000 |
Why?
|
Models, Cardiovascular | 1 | 1991 | 977 | 0.000 |
Why?
|
Models, Biological | 1 | 2001 | 9468 | 0.000 |
Why?
|
Child, Preschool | 1 | 2007 | 42056 | 0.000 |
Why?
|
Computer Simulation | 1 | 1997 | 6218 | 0.000 |
Why?
|
Rats | 1 | 1991 | 23709 | 0.000 |
Why?
|
Concepts
(288)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(35)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_